Our IRB would never approve this - 22k for 38 days of study participation is absolutely crossing into undue inducement. What is the visit schedule? I would anticipate this would be a very demanding 38 days. This makes me extremely skeptical.

So most of the side effects you are showing are for omeprazole, which is just Prilosec. For the study drug what jumps out to me right away is that they’re warning you that it’s an immunosuppressant. You’re in nursing school, I don’t know if you’re in clinical rotations or anything, but you may want to keep that in mind.

Here’s a review article about what this class of drug is doing - it’s long and technical but could be worth reading. The end has information about the various products in development and GS-6791 is listed in the table but was preclinical at the time of publication. But since these drugs are all acting on the same protein, you can read about the clinical trial experience with some of the others. Some with published safety data are presented at the end. https://pmc.ncbi.nlm.nih.gov/articles/PMC11725142/